ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432,025 | +7.9% | 7,441 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $400,550 | +142.9% | 7,441 | +79.2% | 0.00% | +100.0% |
| Q1 2023 | $164,917 | +80741.7% | 4,152 | -18.0% | 0.00% | 0.0% |
| Q4 2022 | $204 | +25.2% | 5,064 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $163 | -99.9% | 5,064 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $143,000 | +38.8% | 4,832 | +32.1% | 0.00% | – |
| Q1 2022 | $103,000 | -28.0% | 3,657 | +17.9% | 0.00% | -100.0% |
| Q4 2021 | $143,000 | +40.2% | 3,103 | 0.0% | 0.00% | – |
| Q3 2021 | $102,000 | -15.0% | 3,103 | -9.6% | 0.00% | – |
| Q2 2021 | $120,000 | -57.0% | 3,434 | -55.5% | 0.00% | -100.0% |
| Q1 2021 | $279,000 | +24.6% | 7,710 | +0.0% | 0.00% | 0.0% |
| Q4 2020 | $224,000 | +7.2% | 7,708 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $209,000 | -1.9% | 7,404 | +12.1% | 0.00% | 0.0% |
| Q2 2020 | $213,000 | -16.5% | 6,602 | +5.5% | 0.00% | 0.0% |
| Q1 2020 | $255,000 | +31.4% | 6,257 | +99.1% | 0.00% | 0.0% |
| Q4 2019 | $194,000 | -26.5% | 3,143 | -13.3% | 0.00% | 0.0% |
| Q3 2019 | $264,000 | -55.5% | 3,627 | -49.7% | 0.00% | -66.7% |
| Q2 2019 | $593,000 | +9.0% | 7,206 | -6.5% | 0.00% | 0.0% |
| Q1 2019 | $544,000 | +73.8% | 7,705 | +10.9% | 0.00% | +50.0% |
| Q4 2018 | $313,000 | -26.9% | 6,948 | -8.1% | 0.00% | 0.0% |
| Q3 2018 | $428,000 | +3.6% | 7,563 | +22.2% | 0.00% | 0.0% |
| Q2 2018 | $413,000 | +10.7% | 6,188 | -3.4% | 0.00% | 0.0% |
| Q1 2018 | $373,000 | -18.2% | 6,404 | -9.5% | 0.00% | 0.0% |
| Q4 2017 | $456,000 | +22.6% | 7,077 | -0.2% | 0.00% | 0.0% |
| Q3 2017 | $372,000 | +5.4% | 7,093 | -5.9% | 0.00% | 0.0% |
| Q2 2017 | $353,000 | -5.4% | 7,541 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $373,000 | +1.9% | 7,541 | +24.8% | 0.00% | 0.0% |
| Q4 2016 | $366,000 | -8.7% | 6,042 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $401,000 | +19.0% | 6,042 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $337,000 | +66.0% | 6,042 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $203,000 | -23.7% | 6,042 | +2.4% | 0.00% | -50.0% |
| Q4 2015 | $266,000 | -33.0% | 5,900 | -7.8% | 0.00% | 0.0% |
| Q2 2015 | $397,000 | -0.8% | 6,400 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $400,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |